Metraipolis › archive › dc_ff757934f237

Cycloastragenol Provides Pharmacokinetic Advantages over Astragaloside IV with Enhanced Cochlear Exposure and Protection Against Age-Associated Hearing… — Europe PMC PMID:42654154

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42654154
DOI
10.3390/pharmaceutics18081037
License (as archived)
solo-consultazione
Archived
2026-10-08T14:17:50.185Z
SHA-256 of the archived text
f10c809bbfdde361641fa46311d27e5eaaf5e5eed246780e1e0299d2bebf2d9c
Stable URL of this page
https://metraipolis.com/documento/dc_ff757934f237

How to cite

Cycloastragenol Provides Pharmacokinetic Advantages over Astragaloside IV with Enhanced Cochlear Exposure and Protection Against Age-Associated Hearing… — Europe PMC PMID:42654154 — Europe PMC (en), https://europepmc.org/article/MED/42654154 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ff757934f237 (Metraipolis archive dc_ff757934f237, sha256 f10c809bbfdde361641fa46311d27e5eaaf5e5eed246780e1e0299d2bebf2d9c)
BibTeX
@misc{dcff757934f237,
  title = {Cycloastragenol Provides Pharmacokinetic Advantages over Astragaloside IV with Enhanced Cochlear Exposure and Protection Against Age-Associated Hearing… — Europe PMC PMID:42654154},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42654154},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ff757934f237; sha256 f10c809bbfdde361641fa46311d27e5eaaf5e5eed246780e1e0299d2bebf2d9c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42654154. Agents can read the archived copy with the MCP tool read_document.